BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9620027)

  • 1. Detection of K-ras point mutations in the supernatants of peritoneal and pleural effusions for diagnosis complementary to cytologic examination.
    Yamashita K; Kuba T; Shinoda H; Takahashi E; Okayasu I
    Am J Clin Pathol; 1998 Jun; 109(6):704-11. PubMed ID: 9620027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.
    Yamashita K; Kida Y; Shinoda H; Kida M; Okayasu I
    Jpn J Cancer Res; 1999 Feb; 90(2):240-8. PubMed ID: 10189896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
    J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas.
    Dai Y; Morishita Y; Mase K; Sato N; Akaogi E; Mitsui T; Noguchi M
    Cancer; 2000 Aug; 90(4):258-63. PubMed ID: 10966568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
    Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
    Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids.
    Dokianakis DN; Varras MN; Papaefthimiou M; Apostolopoulou J; Simiakaki H; Diakomanolis E; Spandidos DA
    Clin Exp Metastasis; 1999 Jun; 17(4):293-7. PubMed ID: 10545015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Motoo Y; Sawabu N
    Pancreas; 2004 Jan; 28(1):13-9. PubMed ID: 14707724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
    Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
    Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures.
    Ajiki T; Onoyama H; Yamamoto M; Fujimori T; Maeda S; Saitoh Y
    Int J Pancreatol; 1995 Dec; 18(3):215-20. PubMed ID: 8708392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
    Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
    Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Restriction enzyme mismatch polymerase chain reaction in the demonstration of Ki-ras-oncogene mutation in carcinoma of the pancreas].
    Heller T; Trautmann B; Zöller-Utz I; König HJ; Liebe S; Ell C; Löhr M
    Dtsch Med Wochenschr; 1995 Jun; 120(23):826-30. PubMed ID: 7781523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of K-ras gene mutation in colorectal cancer tissue by capillary electrophoresis].
    Shi D; Wang R; Xie H; Tian W; Jia Z; Guo J
    Se Pu; 2013 Jun; 31(6):582-6. PubMed ID: 24063200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance of G to A codon 12 mutation K-ras gene in Dukes' B colorectal cancer.
    Zulhabri O; Rahman J; Ismail S; Isa MR; Wan Zurinah WN
    Singapore Med J; 2012 Jan; 53(1):26-31. PubMed ID: 22252179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.
    Tamagawa E; Ueda M; Takahashi S; Sugano K; Uematsu S; Mukai M; Ogata Y; Kitajima M
    Clin Cancer Res; 1997 Nov; 3(11):2143-9. PubMed ID: 9815608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of K-ras oncogene mutation directly applied to atypical cell clusters on cytologic smear slides of bile and pancreatic juice.
    Fukushima N; Suzuki M; Fukayama M
    Pathol Int; 1998 Jan; 48(1):33-40. PubMed ID: 9589462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the relation between mutant gene in bile and hepatic metastasis of large intestinal carcinoma].
    Li S; Yu B; An P; Yuan S; Liang Z
    Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):106-7. PubMed ID: 11829795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of K-ras point mutations in mesenteric venous blood from colorectal cancer patients by enriched polymerase chain reaction and single-strand conformation polymorphism analysis.
    Fujita S; Sugano K; Fukayama N; Moriya Y; Sugihara K; Akasu T
    Jpn J Clin Oncol; 1996 Dec; 26(6):417-21. PubMed ID: 9001346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.